Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Austria and Denmark break ranks with EU to produce vaccines with Israel

Published 2021-03-02, 05:47 a/m
Updated 2021-03-02, 05:54 a/m
© Reuters. Mass vaccination programme for healthcare workers in Vienna

By Francois Murphy and Jacob Gronholt-Pedersen

VIENNA/COPENHAGEN (Reuters) - Austria and Denmark, chafing at the slow rollout of COVID-19 vaccines in the European Union, have broken ranks with Brussels to form an alliance with Israel to produce second-generation vaccines against mutations of the coronavirus.

The move by the two EU member states comes amid rising anger over delays in ordering, approving and distributing vaccines that have left the 27-member bloc trailing far behind Israel's world-beating vaccination campaign.

Austrian Chancellor Sebastian Kurz said while the principle that the EU procures vaccines for member states was correct, the European Medicines Agency (EMA) had been too slow to approve them and lambasted pharmaceutical companies' supply bottlenecks.

"We must therefore prepare for further mutations and should no longer be dependent only on the EU for the production of second-generation vaccines," the conservative chancellor said in a statement on Tuesday.

Danish Prime Minister Danish Mette Frederiksen was also critical of the EU's vaccine programme.

“I don’t think it can stand alone, because we need to increase capacity. That is why we are now fortunate to start a partnership with Israel," she told reporters on Monday.

When asked if Denmark and Austria wanted to take unilateral action in obtaining vaccines, Frederiksen said: “You can call it that.”

Kurz and Frederiksen are due to travel to Israel this week to see Israel's rapid vaccine roll-out up close.

SIDE ORDERS

A growing number of EU countries have placed side orders for doses of vaccines from Russia and China, even though the EMA has yet to rule on whether they are both safe and effective.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Slovakia on Monday ordered 2 million doses of Russia's Sputnik V vaccine. It expects half to arrive this month as it looks to step up vaccinations amid a surge in COVID-19 infections and deaths.

The neighbouring Czech Republic - currently facing the worst COVID-19 outbreak of any EU country - is also considering ordering Russia's Sputnik V.

Hungary, meanwhile, has taken delivery of a vaccine developed by China's Sinopharm, with Prime Minister Viktor Orban announcing on Sunday that he had received the shot.

FIRST MOVERS

Kurz said Austria and Denmark, as members of the First Mover Group, would work with Israel on vaccine production against mutations of the coronavirus and jointly research treatment options.

Experts reckon that Austria will have to vaccinate two-thirds of the population, equivalent to more than 6 million people annually, in the coming years, Kurz said.

He said he would inspect pharmaceutical companies with domestic production including Pfizer (NYSE:PFE), Novartis. Polymun and Boehringer Ingelheim as well as speak to leading scientists and physicians on Tuesday.

Germany last month set up a task force to address bottlenecks in the supply chain of vaccine production and boost local manufacturing to protect itself against future pandemics.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.